Chiral Molecular Graph Encoder for Medication Recommendation

Drug recommendation as an auxiliary medical tool has garnered significant attention from researchers in recent years, primarily due to its potential in identifying effective combination therapy drugs for patients. However, a major challenge arises with naturally occurring chiral drugs, which possess the property that molecules with identical structures can exhibit entirely opposite pharmacological effects. Existing methods often relying on graph structure learning techniques such as graph neural networks, fail to address this issue, leading to safety concerns when recommending chiral drugs. To address the limitations of graph neural network methods in distinguishing chiral drugs with identical molecular structures, we propose a novel chiral molecular graph encoder named ChiMedRec. This encoder employs a fine-grained molecular representation method, incorporating both the original and chiral graph perspectives, thereby effectively differentiating the pharmacological properties of chiral drugs. Experimental results on two public datasets demonstrate that the proposed method significantly improves the performance of drug combination recommendations by considering the molecular chirality of drugs.

Authors

Institutions

Publication Details

Published
2024-12-03
DOI
https://doi.org/10.1109/bibm62325.2024.10822474
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chiral Molecular Graph Encoder for Medication Recommendation

Haifeng Liu, Zheyan Ji, Nan Zhao, Weiguang Qu et al.
Computational Drug Discovery Methods
article

Chiral Molecular Graph Encoder for Medication Recommendation

Haifeng Liu, Zheyan Ji, Nan Zhao, Weiguang Qu, Junsheng Zhou
article en

Abstract

Drug recommendation as an auxiliary medical tool has garnered significant attention from researchers in recent years, primarily due to its potential in identifying effective combination therapy drugs for patients. However, a major challenge arises with naturally occurring chiral drugs, which possess the property that molecules with identical structures can exhibit entirely opposite pharmacological effects. Existing methods often relying on graph structure learning techniques such as graph neural networks, fail to address this issue, leading to safety concerns when recommending chiral drugs. To address the limitations of graph neural network methods in distinguishing chiral drugs with identical molecular structures, we propose a novel chiral molecular graph encoder named ChiMedRec. This encoder employs a fine-grained molecular representation method, incorporating both the original and chiral graph perspectives, thereby effectively differentiating the pharmacological properties of chiral drugs. Experimental results on two public datasets demonstrate that the proposed method significantly improves the performance of drug combination recommendations by considering the molecular chirality of drugs.

Nanjing University of Chinese Medicine (CN), Nanjing Normal University (CN), Nanjing University of Aeronautics and Astronautics (CN)
National Science Foundation, HORIZON EUROPE Health
Openalex Percentile: Top 70%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.